RxDoctor Payments Data

Michael Somenek

Otolaryngology/Facial Plastic Surgery · Washington, DCNPI 1881853448

Payments from drug & device makers

$769,796in general payments, 2019–2025

Across 542 payments — averaging $1420.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Galderma Laboratories, L.p.$702K
  • Merz North America, Inc.$46K
  • AbbVie$17K
  • Galderma Research & Development, LLC$3K
  • Stryker$520
  • Sientra, Inc.$294
  • plus $318 from 4 others
$10,855in research payments, 2019–2025

Across 6 payments — averaging $1809.13 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Galderma Laboratories, L.p.$11K

What the payments were for

  • Consulting fees$217,07534%
  • Speaking & faculty fees$348,86054%
  • Travel & lodging$59,6049%
  • Food & beverage$18,2703%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few otolaryngology/facial plastic surgery providers in District of Columbiato place this figure against a meaningful peer group, so we don't.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cefadroxil14$68
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen11$32

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Washington

Where these figures come from

Is this you, or does something look wrong? →